Evidence map›Paper›PMID 28630288›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Intact piRNA pathway prevents L1 mobilization in male meiosis.

Simon J Newkirk, Suman Lee, Fiorella C Grandi, Valeriya Gaysinskaya, James M Rosser, Nicole Vanden Berg, Cathryn A Hogarth, Maria C N Marchetto, Alysson R Muotri, Michael D Griswold and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
22.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. piRNA loss unleashes episodic transposition bursts.bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. YY1 is a transcriptional activator of mouse LINE-1 Tf subfamily.bioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Simon J NewkirkDepartment of Pharmaceutical Sciences, South Dakota State University, Brookings, SD 57007.
Suman LeeDepartment of Pharmaceutical Sciences, South Dakota State University, Brookings, SD 57007.
Fiorella C GrandiSchool of Molecular Biosciences, Washington State University, Pullman, WA 99164.
Valeriya GaysinskayaDepartment of Embryology, Carnegie Institution of Washington, Baltimore, MD 21218.
James M RosserSchool of Molecular Biosciences, Washington State University, Pullman, WA 99164.
Nicole Vanden BergDepartment of Pharmaceutical Sciences, South Dakota State University, Brookings, SD 57007.
Cathryn A HogarthSchool of Molecular Biosciences, Washington State University, Pullman, WA 99164.
Maria C N MarchettoLaboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA 92037.
Alysson R MuotriLaboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA 92037.
Michael D GriswoldSchool of Molecular Biosciences, Washington State University, Pullman, WA 99164.
Ping YeDepartment of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD 57105.
Alex BortvinDepartment of Embryology, Carnegie Institution of Washington, Baltimore, MD 21218.
Fred H GageLaboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA 92037; gage@salk.edu wenfeng.an@sdstate.edu.
Jef D BoekeInstitute for Systems Genetics, New York University Langone Medical Center, New York, NY 10016.ORCID 0000-0001-5322-4946
Wenfeng AnDepartment of Pharmaceutical Sciences, South Dakota State University, Brookings, SD 57007; gage@salk.edu wenfeng.an@sdstate.edu.ORCID 0000-0002-5659-7120
South Dakota State University · USWashington State University · USSalk Institute for Biological Studies · USCarnegie Institution for Science · USNYU Langone Health · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?P01AG051449 · NIA · BROWN UNIVERSITY · PI Jef D BOEKE · 2016 to 2026
$30.4M
Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
CELLULAR AND MOLECULAR BIOLOGYT32GM007231 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VAN DOREN, MARK B · 1985 to 2020
$18.4M
Training CoreP50GM107632 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BOEKE, JEF D · 2013 to 2017
$10.0M
TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
L1 Retrotransposon and Neural DiversityR01MH088485 · NIMH · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI GAGE, FRED H · 2009 to 2012
$1.5M
Investigating an Etiological Role of LINE-1 Retrotransposition in Birth DefectsR21HD080143 · NICHD · SOUTH DAKOTA STATE UNIVERSITY · PI AN, WENFENG · 2015 to 2016
$400k
Novel Transgenic Mouse Models for L1 Retrotransposons in Development and DiseaseR21OD017965 · OD · SOUTH DAKOTA STATE UNIVERSITY · PI AN, WENFENG · 2015 to 2016
$393k
NCI NIH HHS P30 CA014195NIA NIH HHS P01 AG051449NICHD NIH HHS R21 HD080143NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620NIGMS NIH HHS P50 GM107632NIGMS NIH HHS T32 GM007231NIGMS NIH HHS T32 GM008336NIH HHS R21 OD017965NIMH NIH HHS R01 MH088485
6 · The paper itself

Abstract

The PIWI-interacting RNA (piRNA) pathway is essential for retrotransposon silencing. In piRNA-deficient mice, L1-overexpressing male germ cells exhibit excessive DNA damage and meiotic defects. It remains unknown whether L1 expression simply highlights piRNA deficiency or actually drives the germ-cell demise. Specifically, the sheer abundance of genomic L1 copies prevents reliable quantification of new insertions. Here, we developed a codon-optimized L1 transgene that is controlled by an endogenous mouse L1 promoter. Importantly, DNA methylation dynamics of a single-copy transgene were indistinguishable from those of endogenous L1s. Analysis of

Indexed as

MeiosisRetroelementsTransgenes5' Untranslated RegionsAnimalsCodonDNA MethylationGene Expression Regulation, DevelopmentalHistonesMaleMethylationMiceMice, TransgenicOpen Reading FramesPhenotypePolymerase Chain Reaction5' Untranslated RegionsCodonHistonesRetroelementsRNA, Small InterferingLINE-1 reporter transgenemeiotic arrestPIWI-interacting RNAretrotranspositionspermatogenesis

Identifiers

PMID28630288
PMCPMC5514719
OpenAlexW2659853895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.